Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1534-1551
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1534
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1534
Associated diseases | Prevalence in IBD (%) | Notes |
PSC | 0.024-0.041 | Higher risk of cholangiocarcinoma and colorectal cancer; IBD shows less severe lesions than IBD alone |
NAFLD | 20-30 | Associated with the use of corticosteroids, long disease duration, severe disease course; Associated with metabolic syndrome |
Viral hepatitis | 1-9 | More common in the elderly; Association with advanced liver fibrosis; Need for anti-viral treatment before starting immunosuppressive drugs; HBV vaccine recommended |
- Citation: Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1534.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1534